Back
Krystal Biotech Stock Price Chart
Sponsored
KRYS
Sponsored
Buffet, Bloomberg & 48 Congress Members Are Buying 1 Sector
Click here for the details.
Sell
49
KRYS
Krystal Biotech
Last Price:
186.80
Seasonality Move:
-0.11%
7 Day Trial
ALL ACCESS PASS
$
7
Nvidia's march to $5 trillion
Click here to see how Nvidia's march to $5 trillion could impact its partners.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Krystal Biotech Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 178.33 | Buy |
20-day SMA: | 174.2 | Buy |
50-day SMA: | 165.78 | Buy |
200-day SMA: | 137.84 | Buy |
8-day EMA: | 179.91 | Buy |
20-day EMA: | 175.2 | Buy |
50-day EMA: | 168.8 | Buy |
200-day EMA: | 144.35 | Buy |
Krystal Biotech Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.63 | Buy |
Relative Strength Index (14 RSI): | 64.6 | Buy |
Chaikin Money Flow: | 475348 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (162.74 - 180.26) | Buy |
Bollinger Bands (100): | (140.48 - 181.74) | Buy |
Krystal Biotech Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Krystal Biotech Stock
Is Krystal Biotech Stock a Buy?
- Krystal Biotech share price is 183.64 while KRYS 8-day simple moving average is 178.33, which is a Buy signal.
- The stock price of KRYS is 183.64 while Krystal Biotech 20-day SMA is 174.20, which makes it a Buy.
- Krystal Biotech 50-day simple moving average is 165.78 while KRYS share price is 183.64, making it a Buy technically.
- KRYS stock price is 183.64 and Krystal Biotech 200-day simple moving average is 137.84, creating a Buy signal.
KRYS Technical Analysis vs Fundamental Analysis
Sell
49
Krystal Biotech (KRYS)
is a Sell
Is Krystal Biotech a Buy or a Sell?
-
Krystal Biotech stock is rated a Sell
The current Krystal Biotech [KRYS] share price is $183.64. The Score for KRYS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Krystal Biotech Stock Info
Market Cap:
5.24B
Price in USD:
183.64
Share Volume:
859.47K
Krystal Biotech 52-Week Range
52-Week High:
191.78
52-Week Low:
93.95
Sell
49
Krystal Biotech (KRYS)
is a Sell
Krystal Biotech Share Price Forecast
-
What is the Krystal Biotech stock price today?
The Krystal Biotech stock price is 183.64 USD today. -
Will KRYS stock go up or go down?
Krystal Biotech> share price is forecast to RISE/FALL based on technical indicators -
Is Krystal Biotech overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Krystal Biotech is overvalued.
Is Krystal Biotech Stock a Buy?
- Krystal Biotech share price is 183.64 while KRYS 8-day exponential moving average is 179.91, which is a Buy signal.
- The stock price of KRYS is 183.64 while Krystal Biotech 20-day EMA is 175.20, which makes it a Buy.
- Krystal Biotech 50-day exponential moving average is 168.80 while KRYS share price is 183.64, making it a Buy technically.
- KRYS stock price is 183.64 and Krystal Biotech 200-day simple moving average is 144.35, creating a Buy signal.
Fundamental Analysis of Krystal Biotech
Is Krystal Biotech a good investment?
- Analysts estimate an earnings increase this quarter of $1.66 per share, an increase next quarter of $0.28 per share, an increase this year of $3.59 per share, and an increase next year of $2.08 per share.
Technical Analysis of Krystal Biotech
Should I short Krystal Biotech stock?
- KRYS Moving Average Covergence Divergence (MACD) indicator is 4.63, suggesting Krystal Biotech is a Buy
- Krystal Biotech Relative Strength Index (RSI) is 64.6, which suggest Krystal Biotech is overbought
- The Bollinger Bands (25) for Krystal Biotech is (162.74 - 180.26), which suggest Krystal Biotech is a Buy
- The Bollinger Bands (100) for Krystal Biotech is (140.48 - 181.74), which suggest Krystal Biotech is a Buy
* Krystal Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.